Method-of-Use Study Assessing the Effect of Naltrexone Sustained Release (SR)/ Bupropion SR on Body Weight and Cardiovascular Risk Factors in Overweight and Obese Subjects
CompletedNCT01764386
Orexigen Therapeutics, IncObesity, Overweight
Start: 2013-02-28End: 2014-09-30Updated: 2015-12-29